Influence of the Sex of Translocation Carrier on Clinical Outcomes of Couples Undergoing Preimplantation Genetic Testing
Molecular Genetics & Genomic Medicine · 2025
DOI: 10.1002/mgg3.70050 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular Genetics & Genomic Medicine, 2025. Verfasst von Zhiping Zhang und 10 weiteren Autor:innen. Beteiligte Einrichtung: Center of Reproductive Medicine, Affiliated Children's Hospital of Shanxi & Women Health Center of Shanxi Medicine University, Taiyuan, Shanxi, China. Hauptthemen laut MEDLINE: Translocation, Genetic, Preimplantation Diagnosis. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 14 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Innovation plan of Medical Science and Technology of "Four in a batch" (2020TD19).
Abstract (Originalsprache)
Introduction
This study investigated the impact of the carrier on transferable blastocyst rate and live birth outcomes in couples with structural chromosomal abnormalities.
Methods
Couples were grouped into reciprocal translocation, Robertsonian translocation, or inversions groups, and clinical data were retrospectively analyzed. Preimplantation genetic testing for chromosomal structural rearrangements (PGT‐SR) was conducted, and pregnancy outcomes were compared.
Results
Embryo euploidy rates between male and female carriers differed nonsignificantly in the reciprocal translocation and inversion groups but significantly among the three groups. In the Robertsonian translocation group, male carriers had a higher embryo euploidy rate than that of female carriers. Sperm density of male carriers with reciprocal and Robertsonian translocation was significantly lower than that of the female carrier in the same group, whereas the difference was non‐significant in the inversion group. The clinical outcomes of embryo transfer post‐PGT were similar regardless of the sex of carriers with structural chromosomal abnormalities. Female carriers with Robertsonian translocations displayed a higher risk of producing embryos with chromosomal abnormalities than male carriers. Pregnancy, live birth, and cumulative live birth rates following a PGT‐SR cycle were similar, irrespective of chromosomal structural rearrangement type, and carrier sex.
Conclusion
Our findings offer valuable information for genetic counseling.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Center of Reproductive Medicine, Affiliated Children's Hospital of Shanxi & Women Health Center of Shanxi Medicine University, Taiyuan, Shanxi, China.
- Yikon Genomics Company Ltd., Suzhou, China.
ORCID-Profile: Zhiping Zhang
Förderung
- Innovation plan of Medical Science and Technology of "Four in a batch" (2020TD19)
Zitieren
APA
Zhang, Z., Chen, J., Zhang, L., Wei, R., Liu, Z., Zhao, D., Bi, X., Liang, L., Zhang, X., Su, D., & Wu, X. (2025). Influence of the Sex of Translocation Carrier on Clinical Outcomes of Couples Undergoing Preimplantation Genetic Testing. Molecular Genetics & Genomic Medicine. https://doi.org/10.1002/mgg3.70050
Vancouver
Zhang Z, Chen J, Zhang L, Wei R, Liu Z, Zhao D, et al. Influence of the Sex of Translocation Carrier on Clinical Outcomes of Couples Undergoing Preimplantation Genetic Testing. Molecular Genetics & Genomic Medicine. 2025. doi:10.1002/mgg3.70050
BibTeX
@article{Zhang2025,
author = {Zhang, Zhiping and Chen, Jiayao and Zhang, Lei and Wei, Ruiyang and Liu, Zhen and Zhao, Dunmei and Bi, Xingyu and Liang, Lixia and Zhang, Xueluo and Su, Dan and Wu, Xueqing},
title = {Influence of the Sex of Translocation Carrier on Clinical Outcomes of Couples Undergoing Preimplantation Genetic Testing},
journal = {Molecular Genetics & Genomic Medicine},
year = {2025},
doi = {10.1002/mgg3.70050}
}
EUVIMED